Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk-stratified maintenance therapy trial in pediatric Crohn's disease
NL-OMON55661Phase 4Active, not recruiting
- Sponsor
- PIBD-Net
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methotrexate, azathioprine, mercaptopurine and adalimumab in Crohn's disease and inflammatory bowel disease (IBD) (4 arms), sponsored by PIBD-Net. Started Apr 2019; status: active, not recruiting.
02
Drugs
03
Conditions
Crohn's diseaseinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON55661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55661.